Confidential Disclosure Agreement Clinical Trials

A Confidential Disclosure Agreement (CDA), also known as a Confidentiality Agreement (NDA) or Confidentiality Agreement, is a legal agreement between at least two parties that describes information that the parties wish to share for specific evaluation purposes, but wish to restrict wider use and dissemination. The parties agree not to disclose the non-public information that is the subject of the agreement. CDAs are often performed when two parties envision a relationship/cooperation and need to understand the other party`s processes, methods, or technologies for the sole purpose of assessing the potential of a future relationship. Jefferson employees cannot execute a CDA in Jefferson`s name. Jefferson CDAs` authorized signatories are the Vice President, Innovation Management (excluding clinical trial-related CDAs) and the Director of the ORA (only for clinical trial-related agreements). A CDA or NDA ensures that the parties protect any confidential information shared from unauthorized use or disclosure. A CDA or NDA is usually limited to a given period of time. Once the terms of the CDA have been negotiated, SP will execute the agreement and send the partially executed agreement to the sponsor or CRO for signature. For industry-sponsored clinical trials, the sponsor or contract research organization (CRO) requires Stanford or PI to generally enter into a confidentiality agreement (NDA) prior to disclosure of the study protocol and other proprietary documents. The NDA protects the confidentiality of study details. An NDA can also be called a Confidential Disclosure Agreement (CDA) or Confidentiality Agreement.

A Confidential Disclosure Agreement (CDA) is a legal contract that obliges the parties to the execution of the agreement not to disclose proprietary information covered by the CDA. A CDA describes the extent of confidential information that the parties wish to share for specific purposes. A CDA is also called a confidentiality agreement (NDA), confidentiality agreement or confidentiality agreement. We use a CDA or NDA to protect confidential information. In industry-sponsored clinical trials, the contract administrator verifies a CDA within one week and returns it to the sponsor or clinical research organization working on behalf of the sponsor.. . . .

Comments are closed.